{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T18:59:00Z","timestamp":1785005940989,"version":"3.55.0"},"reference-count":32,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:00:00Z","timestamp":1651622400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:00:00Z","timestamp":1651622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:00:00Z","timestamp":1651622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World j. surg."],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>It is occasionally difficult to diagnose cT3 or cT4b using imaging examinations for esophageal cancer. The optimal treatment strategy for borderline resectable esophageal squamous cell carcinoma (BR\u2010ESCC) is unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We included 131 patients with cT3 ESCC who received neoadjuvant chemoradiotherapy (NCRT) followed by surgery. The patients were classified as having definitive cT3 (D\u2010cT3) or borderline resectable cT3 (BR\u2010cT3), based on presence of undeniable adjacent organ invasion on pretreatment CT. Surgical outcomes and prognoses were compared among patients with D\u2010cT3 and BR\u2010cT3 tumors, and the risk factors for non\u2010R0 resection were assessed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Ninety and 41 patients were classified as D\u2010cT3 and BR\u2010cT3, respectively. Although BR\u2010cT3 had a significantly higher non\u2010R0 resection rate than D\u2010cT3 (D\u2010cT3 3.7%; BR\u2010cT3 14.6%), BR\u2010cT3 was not correlated with shorter overall survival (OS) (D\u2010cT3 5\u2010year OS, 50.8%; BR\u2010cT3 5\u2010year OS 38.4%; <jats:italic>p<\/jats:italic>\u2009=\u20090.234). Conversely, non\u2010R0 resection was significantly associated with poor OS (R0 resection 5\u2010year OS 48.8%; non\u2010R0 resection 5\u2010year OS 22.2%; <jats:italic>p<\/jats:italic>\u2009=\u20090.031). Cox regression analysis of OS demonstrated that BR\u2010cT3 was not a prognostic factor. In the analysis of risk factors for non\u2010R0 resection, BR\u2010cT3 (<jats:italic>p<\/jats:italic>\u2009=\u20090.027), suspected invasion of the trachea or bronchus (<jats:italic>p<\/jats:italic>\u2009=\u20090.046), and high SUVmax of the primary lesion after NCRT (<jats:italic>p<\/jats:italic>\u2009=\u20090.002) were risk factors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>NCRT followed by surgery achieved a relatively high R0 resection rate and an almost equal overall survival rate for BR\u2010cT3 compared with D\u2010cT3 ESCC. Thus, NCRT followed by surgery is an effective treatment strategy for patients with BR\u2010cT3 ESCC.<\/jats:p><\/jats:sec>","DOI":"10.1007\/s00268-022-06568-z","type":"journal-article","created":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T18:04:38Z","timestamp":1651687478000},"page":"1934-1943","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Evaluation of Neoadjuvant Chemoradiotherapy Followed by Surgery for Borderline Resectable Esophageal Squamous Cell Carcinoma"],"prefix":"10.1002","volume":"46","author":[{"given":"Ryosuke","family":"Hirohata","sequence":"first","affiliation":[{"name":"Department of Surgical Oncology Hiroshima University 1\u20132\u20133 Kasumi, Minami\u2010Ku 734\u20138551 Hiroshima Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Hamai","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology Hiroshima University 1\u20132\u20133 Kasumi, Minami\u2010Ku 734\u20138551 Hiroshima Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hihara","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology Hiroshima University 1\u20132\u20133 Kasumi, Minami\u2010Ku 734\u20138551 Hiroshima Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Emi","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology Hiroshima University 1\u20132\u20133 Kasumi, Minami\u2010Ku 734\u20138551 Hiroshima Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Kurokawa","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology Hiroshima University 1\u20132\u20133 Kasumi, Minami\u2010Ku 734\u20138551 Hiroshima Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Yoshikawa","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology Hiroshima University 1\u20132\u20133 Kasumi, Minami\u2010Ku 734\u20138551 Hiroshima Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manato","family":"Ohsawa","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology Hiroshima University 1\u20132\u20133 Kasumi, Minami\u2010Ku 734\u20138551 Hiroshima Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nao","family":"Kitasaki","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology Hiroshima University 1\u20132\u20133 Kasumi, Minami\u2010Ku 734\u20138551 Hiroshima Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morihito","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology Hiroshima University 1\u20132\u20133 Kasumi, Minami\u2010Ku 734\u20138551 Hiroshima Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,5,4]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159\u20108290.CD\u201012\u20100189"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.08.054"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470\u20102045(11)70142\u20105"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112088"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2008.11.001"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.9593"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470\u20102045(15)00040\u20106"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyh107"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/jrr\/rraa110"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/jrr\/rry047"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434\u2010020\u201009106\u20100"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.14442"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00595\u2010021\u201002277\u20107"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434\u2010021\u201009875\u20102"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434\u2010019\u201008124\u2010x"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00268\u2010017\u20104430\u20108"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.21037\/acs.2017.03.14"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0720\u2010048X(02)00030\u2010X"},{"key":"e_1_2_8_20_1","first-page":"3495","article-title":"Treatment outcomes and prognostic factors for thoracic esophageal cancer with clinical evidence of adjacent organ invasion","volume":"33","author":"Hamai Y","year":"2013","journal-title":"Anticancer Res"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/dote.12207"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2016.04.011"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280\u2010012\u20101853\u20107"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"e_1_2_8_25_1","doi-asserted-by":"crossref","unstructured":"Japanese classification of esophageal cancer(2017)Esophagus 14 part II and III 11th edn. p37\u201365","DOI":"10.1007\/s10388-016-0556-2"},{"key":"e_1_2_8_26_1","first-page":"3535","article-title":"Docetaxel plus 5\u2010fluorouracil and cisplatin (DCF) induction chemotherapy for locally advanced borderline\u2010resectable T4 esophageal cancer","volume":"31","author":"Yokota T","year":"2011","journal-title":"Anticancer Res"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyz112"},{"key":"e_1_2_8_28_1","first-page":"1623","article-title":"Chemoradiotherapy of locally advanced esophageal cancer: long\u2010term follow\u2010up of a prospective randomized trial (RTOG 85\u201301)","volume":"281","author":"Cooper JS","year":"1999","journal-title":"Radiat Ther Oncol Group JAMA"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.06.033"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2018.11.036"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1072\u20107515(00)00757\u20102"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10388\u2010017\u20100580\u2010x"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10147\u2010017\u20101168\u20100"}],"container-title":["World Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00268-022-06568-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00268-022-06568-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00268-022-06568-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/s00268-022-06568-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T17:04:09Z","timestamp":1703351049000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1007\/s00268-022-06568-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,4]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["10.1007\/s00268-022-06568-z"],"URL":"https:\/\/doi.org\/10.1007\/s00268-022-06568-z","archive":["Portico"],"relation":{},"ISSN":["0364-2313","1432-2323"],"issn-type":[{"value":"0364-2313","type":"print"},{"value":"1432-2323","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,4]]},"assertion":[{"value":"25 March 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This study was approved by the Institutional Review Board of Hiroshima University (Ethical Committee for Epidemiology of Hiroshima University, E-2225).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}